ID

34387

Descripción

Influence of Probiotics Administration Before Liver Resection in Liver Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02021253

Link

https://clinicaltrials.gov/show/NCT02021253

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 7/10/20 7/10/20 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Liver Fibrosis NCT02021253

Eligibility Liver Fibrosis NCT02021253

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
agreement signed by the patient
Descripción

ID.1

Tipo de datos

boolean

diagnosis of hcc confirmed
Descripción

ID.2

Tipo de datos

boolean

diagnosis of liver disease (score f3 or f4) confirmed
Descripción

ID.3

Tipo de datos

boolean

indication of surgical resection confirmed and validated by a specialist multidisciplinary assessment meeting of gastrointestinal oncology
Descripción

ID.4

Tipo de datos

boolean

patient operable (no indication against anaesthesiological)
Descripción

ID.5

Tipo de datos

boolean

resectable tumor lesion (surgical expertise)
Descripción

ID.6

Tipo de datos

boolean

laboratory tests and endoscopy: no suspicion of severe portal hypertension with bleeding risk
Descripción

ID.7

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient not willing, at risk of default of compliance, or patient can not be monitored regularly
Descripción

ID.8

Tipo de datos

boolean

antibiotic extended or terminated for less than 1 month, may limit the effects of taking probiotics.
Descripción

ID.9

Tipo de datos

boolean

inflammatory bowel disease, which could skew the results expected by taking probiotics results.
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Liver Fibrosis NCT02021253

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
agreement signed by the patient
boolean
ID.2
Item
diagnosis of hcc confirmed
boolean
ID.3
Item
diagnosis of liver disease (score f3 or f4) confirmed
boolean
ID.4
Item
indication of surgical resection confirmed and validated by a specialist multidisciplinary assessment meeting of gastrointestinal oncology
boolean
ID.5
Item
patient operable (no indication against anaesthesiological)
boolean
ID.6
Item
resectable tumor lesion (surgical expertise)
boolean
ID.7
Item
laboratory tests and endoscopy: no suspicion of severe portal hypertension with bleeding risk
boolean
Item Group
C0680251 (UMLS CUI)
ID.8
Item
patient not willing, at risk of default of compliance, or patient can not be monitored regularly
boolean
ID.9
Item
antibiotic extended or terminated for less than 1 month, may limit the effects of taking probiotics.
boolean
ID.10
Item
inflammatory bowel disease, which could skew the results expected by taking probiotics results.
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial